Pfizer gets FDA nod for Xeljanz for joint disease treatment Ruby Khatun Khatun17 Dec 2017 10:30 AM ISTU.S. drugmaker Pfizer Inc said on Thursday the U.S. Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for treatment of a joint...
Medtronic settles states probe into Infuse marketing for 12 million dollars Ruby Khatun Khatun17 Dec 2017 10:15 AM ISTBOSTON: Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse...
MedGenome receives accreditation from the College of American Pathologists Ruby Khatun Khatun17 Dec 2017 10:00 AM ISTBengaluru: MedGenome, India’s market leader in genetic diagnostics announced that its NGS (Next Generation Sequencing) technology based clinical...
Merck's Keytruda fails pivotal gastric cancer trial Ruby Khatun Khatun17 Dec 2017 9:45 AM ISTMerck & Co Inc said on Thursday a key late-stage trial testing its blockbuster drug, Keytruda, failed to meet its main goal of extending lives of...
Merck to make new bid to enter US multiple sclerosis pill market Ruby Khatun Khatun17 Dec 2017 9:30 AM ISTFRANKFURT: Germany’s Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales...
1700 percent on items charged by Fortis Memorial Research Institute, says NPPA Ruby Khatun Khatun16 Dec 2017 4:47 PM ISTGurugram: Fortis hospital at Gurugram charged as high as 1700 percent cent margin on consumables and medicines used for the treatment of a dengue...
Torrent completes acquisition of branded business of Unichem Labs Ruby Khatun Khatun16 Dec 2017 3:58 PM ISTNew Delhi: Torrent Pharmaceuticals said it has completed the Rs 3,600 crore acquisition of Unichem's branded business for India and Nepal.The...
MTaI response to knee implant price control Ruby Khatun Khatun16 Dec 2017 10:30 AM ISTNew Delhi: Patient access is an indisputable goal. The ways governments try to reach it are many. The easier methods are usually unfruitful. A deeper...
Singapore institutes collaborate with Samsung Medical Center to improve treatment of liver cancer Ruby Khatun Khatun16 Dec 2017 10:15 AM ISTSINGAPORE: Scientists and doctors from Singapore institutes are collaborating with Samsung Medical Center (SMC), a leading academic medical center in...
FDA proposes new fast path to market for certain medical devices Ruby Khatun Khatun16 Dec 2017 10:00 AM ISTThe U.S. Food and Drug Administration on Monday proposed creating a new fast track to market for certain medical devices and a potential reduction in...
Bumper crop of new drugs fails to lift big pharma Research and Development returns Ruby Khatun Khatun16 Dec 2017 9:45 AM ISTLONDON: It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on...
Sanofi pins hopes on new drugs after setbacks Ruby Khatun Khatun16 Dec 2017 9:30 AM ISTPARIS: Sanofi’s promising pipeline of experimental drugs can help it overcome setbacks including the low uptake of a new cholesterol treatment and...
